Jpmorgan Chase & Co »

Cue Biopharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $59k 22k 2.64
2023-09-30 $52k 22k 2.30
2023-06-30 $100k 28k 3.64
2023-03-31 $0 39 0.00
2022-12-31 $0 39 0.00
2022-06-30 $0 39 0.00
2022-03-31 $116k 15k 7.94
2021-12-31 $201k 12k 16.67
2021-03-31 $238k 11k 21.28
2020-12-31 $165k 13k 12.54
2020-09-30 $165k 11k 15.38
2020-06-30 $229k 9.3k 24.56
2020-03-31 $93k 6.6k 14.20
2019-12-31 $108k 6.8k 15.87
2019-09-30 $54k 6.4k 8.40
2019-06-30 $38k 5.0k 7.67
2019-03-31 $33k 4.3k 7.65
2018-12-31 $21k 4.5k 4.65
2018-09-30 $37k 4.1k 9.04
2018-06-30 $43k 3.6k 11.98
2018-03-31 $25k 1.8k 13.93